Want to see JP:4935 full AI Analyst Report?
Top Page
Liberta Co., Ltd.
(4935)
Select Model
Select Model
Rating:46Neutral
Price Target:
¥170.00
▼(-31.45% Downside)
Action:Reiterated
Date:09/29/26
The score is primarily held back by weak financial quality—very thin profitability, rising leverage, and negative operating/free cash flow in 2024–2025. Technicals show only a short-term bounce while longer-term trend indicators remain bearish, and valuation support is limited due to a negative P/E and a modest dividend yield.
Positive Factors
Accelerating Revenue Growth
The return to strong revenue growth indicates improving demand and renewed commercial traction after a stagnant period. If sustained, higher sales can broaden the customer base, improve operating leverage, and provide a platform for rebuilding profitability over the next several quarters.
Negative Factors
Very Thin Profitability
Profitability is too thin to provide much protection against ordinary cost or demand pressure, while the recent loss shows earnings remain inconsistent. Even with revenue growth, limited operating profit reduces internal funding capacity and makes sustained improvement dependent on tighter execution.
Read all positive and negative factors
Positive Factors
Negative Factors
Accelerating Revenue Growth
The return to strong revenue growth indicates improving demand and renewed commercial traction after a stagnant period. If sustained, higher sales can broaden the customer base, improve operating leverage, and provide a platform for rebuilding profitability over the next several quarters.
Read all positive factors
Liberta Co., Ltd. (4935) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥6.63B
Dividend Yield1.16%
Average Volume (3M)998.36K
Price to Earnings (P/E)―
Beta (1Y)2.42
Revenue Growth23.15%
EPS Growth66.79%
CountryJP
Employees136
SectorGeneral
Sector StrengthN/A
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)-1.74
Shares Outstanding34,354,200
10 Day Avg. Volume2,376,899
30 Day Avg. Volume998,359
Financial Highlights & Ratios
PEG Ratio-0.67
Price to Book (P/B)6.16
Price to Sales (P/S)0.98
P/FCF Ratio-23.83
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)7.2
Revenue Forecast (FY)¥11.62B
Liberta Co., Ltd. Business Overview & Revenue Model
Company Description
Liberta Co.,Ltd., established in Tokyo, Japan, in 1997, operates globally, focusing on the development and sale of a wide array of goods. Its primary offerings include beauty products, everyday household items, and specialized performance apparel....
How the Company Makes Money
Liberta generates revenue primarily by selling its products to customers via wholesale distribution to retailers and through direct-to-consumer channels such as e-commerce. Its earnings are driven by product sales volume and gross margin on goods ...
Liberta Co., Ltd. Financial Statement Overview
Summary
Income Statement
52
Neutral
Balance Sheet
32
Negative
Cash Flow
22
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.66B | 10.03B | 8.64B | 7.09B | 6.64B | 5.03B |
| Gross Profit | 4.31B | 4.07B | 3.34B | 2.85B | 2.60B | 2.15B |
| EBITDA | 190.42M | 372.86M | 259.90M | 318.19M | 308.32M | 286.75M |
| Net Income | -55.44M | 46.33M | -21.17M | 111.33M | 114.51M | 200.23M |
Balance Sheet | ||||||
| Total Assets | 8.56B | 7.81B | 6.51B | 5.60B | 5.40B | 2.95B |
| Cash, Cash Equivalents and Short-Term Investments | 1.34B | 1.20B | 1.01B | 880.52M | 986.20M | 947.59M |
| Total Debt | 4.83B | 4.12B | 3.44B | 2.49B | 2.44B | 825.45M |
| Total Liabilities | 7.05B | 6.22B | 4.94B | 3.97B | 3.83B | 1.63B |
| Stockholders Equity | 1.51B | 1.59B | 1.57B | 1.63B | 1.57B | 1.32B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -411.66M | -624.92M | 311.02M | -825.23M | 391.70M |
| Operating Cash Flow | 0.00 | -305.76M | -577.34M | 414.13M | -799.26M | 416.57M |
| Investing Cash Flow | 0.00 | -90.48M | -202.74M | -144.96M | -692.94M | -51.12M |
| Financing Cash Flow | 0.00 | 570.81M | 885.84M | -400.30M | 1.51B | -410.29M |
Liberta Co., Ltd. Technical Analysis
Negative
248.00
Price Trends
218.60
Negative
238.73
Negative
279.01
Negative
Market Momentum
-12.95
Negative
44.22
Neutral
71.38
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4935, the sentiment is Negative. The current price of 248 is above the 20-day moving average (MA) of 184.95, above the 50-day MA of 218.60, and below the 200-day MA of 279.01, indicating a bearish trend. The MACD of -12.95 indicates Negative momentum. The RSI at 44.22 is Neutral, neither overbought nor oversold. The STOCH value of 71.38 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4935.
Liberta Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥6.35B | 9.32 | ― | 2.39% | 0.16% | 6.35% | |
73 Outperform | ¥1.68B | 8.71 | ― | 5.05% | -6.17% | -55.84% | |
67 Neutral | ¥39.42B | 17.29 | ― | 1.04% | 13.71% | -16.12% | |
65 Neutral | ¥5.27B | 29.08 | ― | 1.61% | 3.17% | -27.27% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
53 Neutral | ¥5.08B | 14.04 | ― | ― | -14.09% | -22.72% | |
46 Neutral | ¥6.63B | -112.64 | ― | 1.16% | 23.15% | 66.79% |
* General Sector Average
JP:4935
Liberta Co., Ltd.
173.00
-224.98
-56.53%
JP:4918
Ivy Cosmetics Corporation
297.00
-30.43
-9.29%
JP:4925
HABA Laboratories, Inc.
1,676.00
27.47
1.67%
JP:4926
C'BON COSMETICS Co., Ltd.
1,246.00
61.45
5.19%
JP:4933
I-ne CO., LTD.
2,124.00
775.59
57.52%
JP:4934
Premier Anti-Aging Co., Ltd.
586.00
-180.00
-23.50%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.